Organization
GRAIL
American biotechnology and pharmaceutical company
Corporate ratings
Grail was rated Medium Risk because it has adopted several race and identity-based policies in employment and advocacy that prioritize preferential treatment over merit, alongside high-risk funding and advocacy practices tied to divisive political causes. While its philanthropic and political action practices were seen as less risky, the company's overall governance shows a pattern of blending business objectives with partisan social initiatives.
- Cancellations
- Discriminatory Philanthropy
- Employment Protection
- Advocacy Bias
- Funding
- Political Actions